The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.
Michael Mitchell
Advertisement
Michael Mitchell is vice-president of chemical development at Schering-Plough Research Institute.
Articles by Michael Mitchell
Advertisement
Latest Updated Articles
- PhRMA Perspectives on Drug Substance Regulatory Filing Issues
February 2nd 2003
Advertisement
Advertisement